The Biopharma Pod podkast

Immunocore CEO: 3rd Big Pharma Eying Unique Cancer Targeting Tech

0:00
5:10
Do tyłu o 15 sekund
Do przodu o 15 sekund
Immunocore is looking for more licensees for its cancer targeting technology following recent discovery and development deals with GSK and Genentech.

Więcej odcinków z kanału "The Biopharma Pod"